Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127163) titled 'A Study on the Efficacy and Safety of Luvomertinib in Pediatric Langerhans Cell Histiocytosis' on June 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital,Sun Yat-sen University
Condition:
Langerhans cell histiocytosis
Intervention:
Traditional chemotherapy regimens group:Treated with Traditional chemotherapy regimens
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-01
Target Sample Size: Traditional chemotherapy regimens group:50;Luvomeitinib group:50;
Countries of Recruitment:
China
To know more, visit https://ww...